Filing #7337315

Available Statements

Solasia Pharma K.K. - filed on May 15, 2024

Comprehensive Income Attributable To

Taxonomy: jpigp-2019

Consolidated Statement Of Changes In Equity

Taxonomy: jpigp-2019

Statement Of Cash Flows

Taxonomy: jpigp-2019

Acquisition Cost

Taxonomy: jpigp-2019

Business Results Of Group

Taxonomy: jpcrp-2013

Classes Of Shares

Taxonomy: jpcrp-2020

Consolidated Statement Of Profit Or Loss

Taxonomy: jpigp-2023

Cover Page

Taxonomy: jpcrp-2021

Current Liabilities

Taxonomy: jpigp-2019

Finance Income

Taxonomy: jpigp-2018

Financial Information

Taxonomy: jpcrp-2018

Financial Information

Taxonomy: jpcrp-2022

Information About Guarantor

Taxonomy: jpcrp-2020

Information About Reference Indices

Taxonomy: jpcrp-2021

Information About Reference Indices

Taxonomy: jpcrp-2021

Information About Reporting Company's Guarantor, Etc.

Taxonomy: jpcrp-2021

Issued Shares

Taxonomy: jpcrp-2020

Material Contracts, Etc.

Taxonomy: jpcrp-2020

Notes - Approval Of Condensed Semi-Annual Consolidated Financial Statements

Taxonomy: jpigp-2018

Notes - Financial Instruments

Taxonomy: jpcrp-2022

Notes - Inventories

Taxonomy: jpigp-2019

Notes - Restatement

Taxonomy: jpcrp-2020

Notes - Segment Information

Taxonomy: jpigp-2019

Notes - Selling, General And Administrative Expenses

Taxonomy: jpigp-2023

Notes To Quarterly Consolidated Financial Statements

Taxonomy: jpcrp-2023

Overview Of Capital Expenditures

Taxonomy: jpcrp-2022

Particulars Of Secondary Distribution

Taxonomy: jpcrp-2019

Place For Application

Taxonomy: jpcrp-2022

Revenue

Taxonomy: jpigp-2018

Sequential Numbers

Taxonomy: jpcrp-2023

Underwriting Of Bonds

Taxonomy: jpcrp-2021

Talk to a Data Expert

Have a question? We'll get back to you promptly.